A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Expanded Access to Rovalpituzumab Tesirine
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain
- Status
- TERMINATED
- Phase
- NA
Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Transformation Into Small Cell Lung Cancer : a Mode of Resistance to Treatment
- Status
- COMPLETED
- Phase
- N/A
NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC
- Status
- SUSPENDED
- Phase
- PHASE1
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3]
- Status
- TERMINATED
- Phase
- PHASE2
PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of PLX2853 in Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC
- Status
- UNKNOWN
- Phase
- PHASE2